Bruker Income Statement
BRKR / Health Care|15 years of annual SEC 10-K data (FY2011-FY2025)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 15 fiscal years. All figures from audited SEC 10-K filings.
Bruker reported $3.4B in revenue and $9M in net loss for FY2025. Revenue has grown at a 5.4% compound annual rate over the past 14 years.
Based on SEC 10-K filings.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3.4B | $3.4B | $3.0B | $2.5B | $2.4B | $2.0B | $2.1B | $431.7M | $1.8B | $1.6B | $1.6B | $1.8B | $1.8B | $1.8B | $1.7B |
| Cost of Revenue | $1.9B | $1.7B | $1.5B | $1.2B | $1.2B | $1.0B | $1.1B | $995.6M | $949.9M | $866.0M | $915.2M | $1.0B | $1.0B | $962.0M | $899.2M |
| Gross Profit | $1.6B | $1.6B | $1.5B | $1.3B | $1.2B | $939.8M | $995.3M | $900.0M | $816.0M | $745.3M | $708.6M | $763.3M | $805.2M | $829.4M | $752.5M |
| SG&A Expense | $946.5M | $893.8M | $729.4M | $607.4M | $561.2M | $468.6M | $500.2M | $444.7M | $415.2M | $389.8M | $392.2M | $451.0M | $437.9M | $440.4M | $406.6M |
| R&D Expense | $395.2M | $376.5M | $294.8M | $235.9M | $220.8M | $198.0M | $187.7M | $173.4M | $161.6M | $147.9M | $145.7M | $174.2M | $190.5M | $195.3M | $177.2M |
| Operating Income | $68.2M | $253.1M | $436.9M | $432.7M | $413.3M | $248.3M | $300.9M | $262.4M | $219.5M | $181.8M | $145.7M | $105.4M | $148.2M | $156.0M | $155.6M |
| Interest Expense | - | $47.9M | $16.4M | $16.1M | $14.3M | $14.4M | $16.0M | $12.6M | $15.4M | $13.2M | $13.0M | $13.3M | $13.4M | $14.3M | $7.3M |
| Income Tax | $29.3M | $91.4M | $117.7M | $116.4M | $113.0M | $64.4M | $82.4M | $63.7M | $117.5M | $23.1M | $23.1M | $41.7M | $42.8M | $60.1M | $51.5M |
| Net Income | -$8.6M | $113.1M | $427.2M | $296.6M | $277.1M | $157.8M | $197.2M | $179.7M | $78.6M | $153.6M | $101.6M | $56.7M | $80.1M | $77.5M | $92.3M |
| EPS (Basic) | $2.92 | $2.00 | $1.83 | $1.03 | $1.27 | $1.15 | $0.50 | $0.95 | $0.60 | $0.34 | $0.48 | $0.47 | $0.56 | $0.58 | $0.50 |
| EPS (Diluted) | $2.90 | $1.99 | $1.81 | $1.02 | $1.26 | $1.14 | $0.49 | $0.95 | $0.60 | $0.33 | $0.48 | $0.46 | $0.55 | $0.58 | $0.49 |
| Shares Outstanding | 151.7M | 145.2M | 147.0M | 150.8M | 152.0M | 154.2M | 156.6M | 155.9M | 159.9M | 165.4M | 168.5M | 167.6M | 166.6M | 165.9M | 165.2M |
| Gross Margin | 45.9% | 49.0% | 51.0% | 51.6% | 50.0% | 47.3% | 48.0% | 208.5% | 46.2% | 46.3% | 43.6% | 42.2% | 43.8% | 46.3% | 45.6% |
| Operating Margin | 2.0% | 7.5% | 14.7% | 17.1% | 17.1% | 12.5% | 14.5% | 60.8% | 12.4% | 11.3% | 9.0% | 5.8% | 8.1% | 8.7% | 9.4% |
| Profit Margin | -0.3% | 3.4% | 14.4% | 11.7% | 11.5% | 7.9% | 9.5% | 41.6% | 4.5% | 9.5% | 6.3% | 3.1% | 4.3% | 4.3% | 5.6% |